Patents by Inventor Robert M. Abrams

Robert M. Abrams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11947519
    Abstract: Examples described herein provide a computer-implemented method that includes defining a key performance indicator associated with a non-instrumented object of a processing system. The method further includes determining a current anomaly level of the key performance indicator for an instrumented object having a relationship with the non-instrumented object. The method further includes assigning an anomaly level to the non-instrumented object based on the current anomaly level.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: April 2, 2024
    Assignee: International Business Machines Corporation
    Inventors: Yuk L. Chan, Anuja Deedwaniya, Robert M. Abrams
  • Publication number: 20230390554
    Abstract: Systems and methods are described, which provides electrical stimulation to a person, while also facilitating delivery of a drug through the system to a target region of the brain. The electrical stimulation to the target region of the brain increases a permeability of a blood brain barrier.
    Type: Application
    Filed: June 5, 2023
    Publication date: December 7, 2023
    Inventors: James William PHILLIPS, Robert M. ABRAMS
  • Patent number: 11775654
    Abstract: Examples described herein provide a computer-implemented method that includes detecting an anomaly associated with an object of a computer system and determining an importance classification of the object. An object relationship of the object is determined with respect to one or more other objects of the computer system. An impact score of the anomaly is determined based on the importance classification and the object relationship. An anomaly report is output with the impact score.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: October 3, 2023
    Assignee: International Business Machines Corporation
    Inventors: Yuk L. Chan, Anuja Deedwaniya, Robert M. Abrams
  • Patent number: 11633189
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: April 25, 2023
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei
  • Patent number: 11556446
    Abstract: A method, system, and computer program product are provided for performance anomaly detection. Velocity data is periodically received from a workload manager for one or more address spaces. An expected velocity value is created for each of the one or more address spaces. A factor of the expected velocity value is compared to a current velocity value from the velocity data. Based on the current velocity value being lower than the factor, a remedial action is generated indicating an anomaly.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: January 17, 2023
    Assignee: International Business Machines Corporation
    Inventors: Robert M. Abrams, Karla Arndt, Friedrich Matthias Gubitz, Dieter Wellerdiek, Nicholas C. Matsakis
  • Publication number: 20220387042
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Application
    Filed: August 17, 2022
    Publication date: December 8, 2022
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
  • Patent number: 11457923
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: October 4, 2022
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
  • Publication number: 20220188218
    Abstract: According to an aspect, a computer-implemented method includes configuring a disaster recovery computer system as a test environment of a mainframe computer system as a mirror image of a production environment, where the disaster recovery computer system is a backup of a primary production computer system. Test cases are executed in the test environment of the disaster recovery computer system. A stress and load impacts can be monitored on a plurality of computer system resources of the disaster recovery computer system based on execution of the test cases. The test environment can be disabled, and the disaster recovery computer system can be reconfigured as a production system based on a failure of the primary production computer system.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 16, 2022
    Inventors: Robert M. Abrams, Marc Henri Coq, Desmond Fitzpatrick, Eugene Sale
  • Publication number: 20220188424
    Abstract: Examples described herein provide a computer-implemented method that includes detecting an anomaly associated with an object of a computer system and determining an importance classification of the object. An object relationship of the object is determined with respect to one or more other objects of the computer system. An impact score of the anomaly is determined based on the importance classification and the object relationship. An anomaly report is output with the impact score.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 16, 2022
    Inventors: Yuk L. Chan, Anuja Deedwaniya, Robert M. Abrams
  • Publication number: 20220191226
    Abstract: Examples described herein provide a computer-implemented method that includes receiving a list of objects with anomaly detection results associated therewith. The method further includes generating a resource graph, wherein the resource graph comprises at least two nodes, each of the at least two nodes being associated with one of the objects. The method further includes determining a relationship between the at least two nodes. The method further includes assigning an anomaly score to at least one of the objects. The method further includes calculating for at least one of the nodes, an overall anomaly score for the at least one of the nodes based on the anomaly score for the at least one of the objects and based on the anomaly score for another node related to the at least one of the nodes.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 16, 2022
    Inventors: Yuk L. Chan, Anuja Deedwaniya, Robert M. Abrams
  • Publication number: 20220188290
    Abstract: Examples described herein provide a computer-implemented method that includes defining a key performance indicator associated with a non-instrumented object of a processing system. The method further includes determining a current anomaly level of the key performance indicator for an instrumented object having a relationship with the non-instrumented object. The method further includes assigning an anomaly level to the non-instrumented object based on the current anomaly level.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 16, 2022
    Inventors: Yuk L. Chan, Anuja Deedwaniya, Robert M. Abrams
  • Patent number: 11341032
    Abstract: According to an aspect, a computer-implemented method includes configuring a disaster recovery computer system as a test environment of a mainframe computer system as a mirror image of a production environment, where the disaster recovery computer system is a backup of a primary production computer system. Test cases are executed in the test environment of the disaster recovery computer system. A stress and load impacts can be monitored on a plurality of computer system resources of the disaster recovery computer system based on execution of the test cases. The test environment can be disabled, and the disaster recovery computer system can be reconfigured as a production system based on a failure of the primary production computer system.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: May 24, 2022
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Robert M. Abrams, Marc Henri Coq, Desmond Fitzpatrick, Eugene Sale
  • Publication number: 20220100628
    Abstract: A method, system, and computer program product are provided for performance anomaly detection. Velocity data is periodically received from a workload manager for one or more address spaces. An expected velocity value is created for each of the one or more address spaces. A factor of the expected velocity value is compared to a current velocity value from the velocity data. Based on the current velocity value being lower than the factor, a remedial action is generated indicating an anomaly.
    Type: Application
    Filed: September 25, 2020
    Publication date: March 31, 2022
    Inventors: Robert M. Abrams, Karla Arndt, Friedrich Matthias Gubitz, Dieter Wellerdiek, Nicholas C. Matsakis
  • Publication number: 20220079601
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Application
    Filed: November 29, 2021
    Publication date: March 17, 2022
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Brent GERBERDING, Robert M. ABRAMS, Gilbert CLARKE
  • Patent number: 11185333
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: November 30, 2021
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Brent Gerberding, Robert M. Abrams, Gilbert Clarke
  • Publication number: 20190365386
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device comprises a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Application
    Filed: August 19, 2019
    Publication date: December 5, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
  • Publication number: 20190336134
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm.
    Type: Application
    Filed: July 1, 2019
    Publication date: November 7, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei
  • Patent number: 10426487
    Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: October 1, 2019
    Assignee: Pulsar Vascular, Inc.
    Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
  • Publication number: 20190223880
    Abstract: Implantable devices for placement at a cavity or opening such as an aneurysm are disclosed. The implantable devices, in a deployed condition, have a generally inverted U-shaped profile with a curved or angled framework support structure sized and configured for placement in proximity to tissue surrounding the opening and anchoring legs extending proximally from the framework structure sized and configured to contact the wall of a neighboring lumen at opposed locations. Occlusive and semi-occlusive membranes may be associated with the framework support structure and deployed over the opening to provide exclusion of the opening and flow diversion. Proximal anchoring segments providing additional lumen wall surface area contact for the implantable device following deployment may be incorporated.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Applicant: PULSAR VASCULAR, INC.
    Inventors: Brent GERBERDING, Robert M. ABRAMS, Gilbert CLARKE
  • Patent number: 10335153
    Abstract: Implantable therapeutic devices and methods for endovascular placement of devices at a target site, such an opening at a neck of an aneurysm, are disclosed. Selected embodiments of the present technology have closures that at least partially occlude the neck of an aneurysm to stabilize embolic or coagulative treatment of the aneurysm. In one embodiment, for example, an aneurysm closure device comprises a closure structure and a supplemental stabilizer. The closure structure can have a curved portion configured to extend along a first vessel, such as a side branch of a bifurcated vessel that extends along a lateral axis. The supplemental stabilizer extends from the closure structure along a longitudinal axis transverse to the lateral axis of the first vessel. The supplemental stabilizer is configured to exert an outward force against a second vessel, such as a parent vessel, that extends transversely to the first vessel.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 2, 2019
    Assignee: PULSAR VASCULAR, INC.
    Inventors: Gilbert Clarke, Brent Gerberding, Robert M. Abrams, Masoud Molaei